Lung Cancer Video Library - Evolving Options in First Line Treatment of ALK-Positive Non-Small Cell Lung Cancer (NSCLC)


Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses evolving options in first line treatment of ALK-Positive non-small cell lung cancer (NSCLC).

Q&A on ALK Inhibitor Therapy, with Drs. Ben Solomon and Ross Camidge


Following the terrific presentations by Drs. Ben Solomon and Ross Camidge on the science and clinical experience with the novel ALK inhibitor XALKORI (crizotinib), we had a question and answer session, which is now available as a podcast. Here's the audio podcast and transcript for it (not really a video component for this one).



Subscribe to ALK-positive